This site is intended for Healthcare Professionals only.

GSK launches shingles vaccine in UK


Share post:

Global pharmaceutical giant GlaxoSmithKline plc (GSK) today (September 1) introduced Shingrix vaccine in the UK which helps to protect adults against shingles.

The vaccine, which also prevents post-herpetic neuralgia (PHN), a common complication of shingles, is licensed to be used for adults of 18 years or older who are at increased risk of shingles.

It will be available for purchase at various pharmacy chains, private GP clinics and other healthcare settings.

From today, the vaccine is also available at the current national shingles immunisation programme for patients who are contraindicated to receive the current vaccine on the programme.

Shingles is a painful condition caused by the reactivation of the varicella zoster virus (VZV), which is also responsible for chickenpox. Nearly 90 per cent of adults in the UK have had chickenpox, hence will have the dormant virus present in their nervous system.

The risk of developing shingles increases with advancing age, particularly in adults above 50 as immune system tend to decline with aging.

Karen Mullen, medical director UK & Ireland, GSK, said: “Shingrix was developed specifically to overcome this decline in immune function and to help protect people as they get older. We are pleased that people in the UK will now have access to this vaccine to help reduce the burden of this painful disease.”

Marian Nicholson, director, Shingles Support Society described the shingles pain as “burning, shooting, stabbing or even constant unbearable itching”.

She said: “some people can experience pain for months, or longer, and it is very difficult to treat. For this reason, we welcome any new options to help prevent shingles and associated pain.”

After the UK launch, GSK aims to boost the global supply of the vaccine to benefit more people worldwide.


Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

#SaveOurPharmacies: NPA distributes fair funding campaign posters, stickers

The National Pharmacy Association (NPA) is distributing new campaign materials to pharmacies across England this week to empower...

Lake District pharmacy grapples with medicine shortages amidst growing crisis

79% of pharmacists fear for patient health according to Community Pharmacy England report A Lake District pharmacy is grappling...

Common antibiotic for whooping cough treatment ‘completely out of stock’ – Dr. Leyla Hannbeck

Whooping cough caused five infant deaths in the first quarter of 2024, according to UKHSA Pharmacists in the UK...

Labour with Nuffield Health to aid thousands of NHS staff with joint pain return to work

Nurses accounted for 52,000 of sick days, doctors for 3,500, both up since 2019 as per the Labour...